King's College London is a public research university located in London, England. King's was established by royal charter in 1829 under the patronage of King George IV and the Duke of Wellington. In 1836, King's became one of the two founding colleges of the University of London.

During the past decade, King's College London conducted 139 clinical trials. In the 10-year time frame, 139 clinical trials started and 23 clinical trials were completed, i.e. on average, 16.5% percent of trials that started reached the finish line to date. In the past 5 years, 70 clinical trials started and 15 clinical trials were completed. i.e. 21.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "King's College London" #1 sponsor was "King's College London" with 82 trials, followed by "Guy's and St Thomas' NHS Foundation Trust" with 4 trials sponsored, "Hoffmann-La Roche" with 4 trials sponsored, "Medtronic Diabetes" with 4 trials sponsored and "Assembly Biosciences" with 4 trials sponsored. Other sponsors include 72 different institutions and companies that sponsored additional 71 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "King's College London" #1 collaborator was "King's College London" with 17 trials as a collaborator, "South London and Maudsley NHS Foundation Trust" with 14 trials as a collaborator, "Guy's and St Thomas' NHS Foundation Trust" with 6 trials as a collaborator, "National Institute for Health Research, United Kingdom" with 5 trials as a collaborator and "University College, London" with 4 trials as a collaborator. Other collaborators include 190 different institutions and companies that were collaborators in the rest 170 trials.

According to Clinical.Site data, the most researched conditions in "King's College London" are "Autism Spectrum Disorder" (9 trials), "Anxiety" (6 trials), "Healthy" (6 trials), "Depression" (5 trials) and "Amyotrophic Lateral Sclerosis" (4 trials). Many other conditions were trialed in "King's College London" in a lesser frequency.

Most popular intervention types in "King's College London" are "Drug" (53 trials), "Other" (42 trials), "Device" (30 trials), "Behavioral" (19 trials) and "Dietary Supplement" (15 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (34 trials), "AMX0035" (2 trials), "Aronia extract" (2 trials), "E/C/F/TAF" (2 trials) and "Etrolizumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "King's College London" are 158 trials for "All" genders, 10 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are 48 active trials in "King's College London". 4 are not yet recruiting, 31 are recruiting, 12 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 92 completed trials in King's College London, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in King's College London, 11 "Phase 1" clinical trials were conducted, 21 "Phase 2" clinical trials and 20 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 81 trials that are defined as “Not Applicable".

King's College London has several departments that took part in Clinical trials: "Diabetes & Nutritional Sciences Division, King's College London" - 14 trials, "Institute of Psychiatry, King's College London" - 32 trials, "St. John's Institute of Dermatology" - 5 trials, "Centre for Anxiety Disorders and Trauma" - 3 trials, "Health Psychology Section" - 2 trials, "King's College Hospital - Haematology Clinical Trials" - 2 trials